Oman vs Sur: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)
Oman
100.0%
in 2014
Sur
61.0%
in 2014
Oman rank
1st
Sur rank
2nd
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) over time
- Oman
- Sur
How they compare
Oman currently reports 100.0% against 61.0% in Sur, a difference of 39.0%.
That makes Oman's figure about 1.6 times Sur's.
Across all 7 years both countries report, Oman has been ahead every year.
Oman ranks 1st and Sur ranks 2nd of 104 countries.
Oman has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Oman | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 9.1% | 91.0% | Oman |
| 2010s | 97.6% | 23.6% | 74.0% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on cpt (co-trimoxazole preventive therapy), Oman or Sur?
- Oman, at 100.0% against 61.0% in Sur as of 2014.
- What is the difference in hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) between Oman and Sur?
- 39.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Sur?
- 7 years are reported by both, from 2008 to 2014.
- How do Oman and Sur rank globally for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Oman ranks 1st and Sur ranks 2nd of 104 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.